Skip to main content
. 2022 Apr 28;17(4):e0267294. doi: 10.1371/journal.pone.0267294

Table 1. Study components, timeline, and sample size per study activity.

Study Component Timeline Sample Size Intervention/Activity
Part A: Vaccination 2018 Dec-2019 Feb All eligible 8,000~9,000* schoolgirls (<15 years old) in Grade 8 per province Udon Thani: single-dose HPV vaccine regimen
Buri Ram: two-dose HPV vaccine regimen 6 months apart
N = 1,500 for SBQ
N = 200 (pre-vaccine serology)
Part B: Baseline CSS 2018 Dec-2019 Feb G10/V1: N = 2,600 schoolgirls per province SBQ and HPV urine prevalence
G12/V3: N = 2,000 schoolgirls per province
Part C: Year 2 CSS 2020 Dec-2021 Feb G10/V1: N = 2,600 schoolgirls per province SBQ and HPV urine prevalence
N = 200 (serology)
Part D: Year 4 CSS 2022 Dec-2023 Feb G12/V3: N = 2,000 schoolgirls per province SBQ and HPV urine prevalence
N = 200 (serology)

*Approximate number of Grade 8 schoolgirls that will be eligible and offered vaccination